This is a true test of the technical strength of nxtm. Do not sell here(and buy more if possible)and we will hold the line. If not, I have a tight stop and will be out too. This is a great opportunity if there is any follow thru from the overall market. nxtm had its crash 1 year ago this month, and has laid down strong support for the last 2 months. With many problems fixed, and without the problems that big pharma is currently facing, downside should be limited. ceph is a great company, but look at the technical damage and the distance to fall for support. Probably a solid short to the high 40's.